References
- Phan AT. Adrenal cortical carcinoma–review of current knowledge and treatment practices. Hematol Oncol Clin North Am 2007;21:489–507 viii.
- Balasubramaniam S, Fojo T. Practical considerations in the evaluation and management of adrenocortical cancer. Semin Oncol 2010;37:619–626.
- Hutchison TA, Shahan DR. DRUGDEX System. Greenwood Village, Colorado2004.
- Terzolo M, Pia A, Berruti A, Osella G, Alì A, Carbone V et al. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab 2000;85:2234–2238.
- Daffara F, De Francia S, Reimondo G, Zaggia B, Aroasio E, Porpiglia F et al. Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Endocr Relat Cancer 2008;15:1043–1053.
- Luo CF, Yuan M, Chen MS, Liu SM, Zhu L, Huang BY et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm 2011;410:138–144.
- Gao Y, Yang R, Zhang Z, Chen L, Sun Z, Li Y. Solid lipid nanoparticles reduce systemic toxicity of docetaxel: Performance and mechanism in animal. Nanotoxicology 2011 Feb 9 (In Press).
- Kakkar V, Singh S, Singla D, Kaur IP. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 2011;55:495–503.
- Rawat MK, Jain A, Singh S. In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats. J Pharm Sci 2011;100:2406–2417.
- Arias JL, Clares B, Morales ME, Gallardo V, Ruiz MA. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets 2011;12:1151–1165.
- Souto EB, Doktorovová S. Chapter 6 – Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery. Meth Enzymol 2009;464:105–129.
- Das S, Chaudhury A. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011;12:62–76.
- Severino P, Souto EB, Santana MHA. Surface response charts for optimizing SLN and NLC: effect of homogenization technique. (Manuscript Submitted.)
- Luykx DM, Peters RJ, van Ruth SM, Bouwmeester H. A review of analytical methods for the identification and characterization of nano delivery systems in food. J Agric Food Chem 2008;56:8231–8247.
- Deshiikan SR, KD P. Modified Booth equation for the calculation of zeta potential. Colloid Polym Sci 1998;276:117–124.
- Ye J, Wang Q, Zhou X, Zhang N. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm 2008;352:273–279.
- Severino P, Pinho SC, Souto EB, Santana MHA. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles. Colloids Surf B 2011;86:125–130.
- Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) – development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007;67:141–148.
- Desai D, Kothari S, Chen W, Wang J, Huang M, Sharma L. Fatty acid and water-soluble polymer-based controlled release drug delivery system. J Pharm Sci 2011;100:1900–1912.
- Jensen LB, Magnussson E, Gunnarsson L, Vermehren C, Nielsen HM, Petersson K. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010;390:53–60.
- Trotta M, Gallarate M, Pattarino F, Morel S. Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions. J Control Release 2001;76:119–128.
- da Silva CF, Severino P, Martins F, Chaud MV, Santana MH. The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac model. J Microencapsul 2009;26:523–528.
- Ammar DA, Noecker RJ, Kahook MY. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Adv Ther 2011;28:501–510.
- Nomura Y, Bhawal UK, Nishikiori R, Sawajiri M, Maeda T, Okazaki M. Effects of high-dose major components in oral disinfectants on the cell cycle and apoptosis in primary human gingival fibroblasts in vitro. Dent Mater J 2010;29:75–83.
- Xue Y, Hieda Y, Kimura K, Takayama K, Fujihara J, Tsujino Y. Kinetic characteristics and toxic effects of benzalkonium chloride following intravascular and oral administration in rats. J Chromatogr B Analyt Technol Biomed Life Sci 2004;811:53–58.
- Xue Y, Hieda Y, Saito Y, Nomura T, Fujihara J, Takayama K et al. Distribution and disposition of benzalkonium chloride following various routes of administration in rats. Toxicol Lett 2004;148:113–123.
- Andersen A, Kasperlik-Zaluska AA, Warren DJ. Determination of mitotane (o,p-DDD) and its metabolites o,p-DDA and o,p-DDE in plasma by high-performance liquid chromatography. Ther Drug Monit 1999;21:355–359.
- Manjunath K, Venkateswarlu V, Hussain A. Preparation and characterization of nitrendipine solid lipid nanoparticles. Pharmazie 2011;66:178–186.
- Silva AC, González-Mira E, García ML, Egea MA, Fonseca J, Silva R et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces 2011;86:158–165.
- Gonzalez-Mira E, Egea MA, Souto EB, Calpena AC, García ML. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2011;22:045101.
- Severino P, Souto EB, Santana MHA, Polymorphic behavior and hydrophile-lipophile balance of lipid nanoparticles for improving drug delivery. 1st International Symposium on Colloids and Materials: New Scientific Horizons; 2011; The Netherlands, Amsterdam.